OP 2.3 – 00117 The EZH2 inhibitor Tazemetostat increases MHC I antigen presentation in vitro and in vivo, enhancing antiviral activities of HIV-specific CTLs

Bibliographic Details
Main Authors:	A. Gramatica, A. Danesh, I. Miller, J. Weiler, F. Khan, D. Copertino, U. Chukwukere, L. Leyre, B. Jones
Format:	Article
Language:	English
Published:	Elsevier 2022-12-01
Series:	Journal of Virus Eradication
Online Access:	http://www.sciencedirect.com/science/article/pii/S2055664022000899

Internet